K263-0290 Screening compound: N~1~-[2-(1-cyclohexenyl)ethyl]-2-({3-[2-(diethylamino)ethyl]-4-oxo-3,4-dihydro[1]benzothieno[3,2-d]pyrimidin-2-yl}sulfanyl)acetamide

K263-0290 Screening compound: N~1~-[2-(1-cyclohexenyl)ethyl]-2-({3-[2-(diethylamino)ethyl]-4-oxo-3,4-dihydro[1]benzothieno[3,2-d]pyrimidin-2-yl}sulfanyl)acetamide
K263-0290 Screening compound: N~1~-[2-(1-cyclohexenyl)ethyl]-2-({3-[2-(diethylamino)ethyl]-4-oxo-3,4-dihydro[1]benzothieno[3,2-d]pyrimidin-2-yl}sulfanyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K263-0290
N~1~-[2-(1-cyclohexenyl)ethyl]-2-({3-[2-(diethylamino)ethyl]-4-oxo-3,4-dihydro[1]benzothieno[3,2-d]pyrimidin-2-yl}sulfanyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K263-0290

Molecular Formula

C26H34N4O2S2 (C26 H34 N4 O2 S2)

Compound Name

N~1~-[2-(1-cyclohexenyl)ethyl]-2-({3-[2-(diethylamino)ethyl]-4-oxo-3,4-dihydro[1]benzothieno[3,2-d]pyrimidin-2-yl}sulfanyl)acetamide

IUPAC name

N-[2-(cyclohex-1-en-1-yl)ethyl]-2-({5-[2-(diethylamino)ethyl]-6-oxo-8-thia-35-diazatricyclo[7.4.0.0^{27}]trideca-1(9)2(7)31012-pentaen-4-yl}sulfanyl)acetamide

SMILES

CCN(CC)CCN(C1=O)C(SCC(NCCC2=CCCCC2)=O)=Nc2c1sc1c2cccc1

InChI

InChI=1S/C26H34N4O2S2/c1-3-29(4-2)16-17-30-25(32)24-23(20-12-8-9-13-21(20)34-24)28-26(30)33-18-22(31)27-15-14-19-10-6-5-7-11-19/h8-10,12-13H,3-7,11,14-18H2,1-2H3,(H,27,31)

InChI Key

WLMYIZSIEBOUQV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15085402

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

498.71

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.478

Distribution Coefficient, logD

2.403

Water Solubility, LogSw

-4.03

Polar Surface Area

52.432

Acid Dissociation Constant (pKa)

15.55

Base Dissociation Constant (pKb)

9.47

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

K263-0290 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Eccentric PPI Library (11937 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Cyclic compounds
  • Mimetics
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with K263-0290 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K263-0290?
Check Price and Availability of K263-0290, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K263-0290 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K263-0290
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K263-0290
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K263-0290 available by request